Health Care & Life Sciences » Biotechnology | D. Western Therapeutics Institute Inc.

D. Western Therapeutics Institute Inc. | Cash Flow

Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
Net Income before Extraordinaries
221,214.00
191,685.00
295,372.00
304,463.00
1,605,843.00
Depreciation, Depletion & Amortization
2,211.00
2,184.00
16,045.00
17,557.00
45,118.00
Other Funds
-
-
-
4,800.00
-
Funds from Operations
203,193.00
191,329.00
269,225.00
304,903.00
600,367.00
Changes in Working Capital
3,443.00
32,198.00
53,450.00
28,655.00
196,848.00
Net Operating Cash Flow
199,750.00
223,527.00
322,675.00
333,558.00
797,215.00
Capital Expenditures
1,841.00
3,130.00
2,565.00
37,769.00
4,301.00
Sale of Fixed Assets & Businesses
-
-
187,690.00
-
-
Purchase/Sale of Investments
1,001,272.00
289,632.00
649,460.00
193,028.00
541,177.00
Net Investing Cash Flow
1,002,991.00
286,502.00
834,584.00
230,797.00
763,123.00
Issuance/Reduction of Debt, Net
-
-
-
-
582,000.00
Net Financing Cash Flow
2,026,131.00
36,961.00
87,912.00
1,066,537.00
1,406,969.00
Net Change in Cash
823,492.00
100,019.00
599,821.00
524,777.00
159,255.00
Free Cash Flow
201,346.00
226,657.00
323,697.00
370,969.00
801,112.00
Net Assets from Acquisitions
-
-
-
-
1,300,000.00
Other Sources
122.00
-
5,000.00
-
-
Change in Capital Stock
2,026,131.00
36,961.00
87,912.00
1,071,337.00
824,969.00
Exchange Rate Effect
102.00
83.00
-
22,595.00
5,886.00
Other Uses
-
-
5,001.00
-
-

About D. Western Therapeutics Institute

View Profile
Address
CK21 Hirokoji-Fushimi Building, 7/F
Nagoya Aichi 460
Japan
Employees -
Website http://www.dwti.co.jp
Updated 09/14/2018
D. Western Therapeutics Institute, Inc. engages in the research and development of pharmaceutical drugs. Its products include ophthalmic solution and agents for anti-platelet and anti-glaucoma.